Vol 8, Supp. A (2017)
Case report
Published online: 2017-12-21

open access

Page views 812
Article views/downloads 664
Get Citation

Connect on Social Media

Connect on Social Media

Pomalidomide in combination with clarithromycin and dexamethasone for double refractory plasma cell myeloma — a case report and review of literature

Agnieszka Szeremet1

Abstract

Pomalidomide is a new immunomodulatory drug used for treatment of plasma cell myeloma (PCM). In this paper, we describe a case report of a woman with PCM who was double refractory to bortezomib and lenalidomide, and was subsequently treated with pomalidomide with clarithromycin and dexamethasone.

Article available in PDF format

View PDF (Polish) Download PDF file



Hematology in Clinical Practice